Login
Home
Charts
Search
Watchlist
Products

Integrated Proteins Ltd

INTEGFD·BSE
13.05-1.88%Tue, 22 Sept '26 15:15

Integrated Proteins Ltd

INTEGFD
BSE
13.05
-1.88%
|Tue, 22 Sept '26 15:15
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
244Cr
Close
Close Price
13.05
Industry
Industry
Trading
PE
Price To Earnings
326.25
PS
Price To Sales
11.95
Revenue
Revenue
20Cr
Rev Gr TTM
Revenue Growth TTM
-4.93%
PAT Gr TTM
PAT Growth TTM
132.00%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
00000021040611
Growth YoY
Revenue Growth YoY%
41.28,854.2-100.0-73.5
Expenses
ExpensesCr
00000021040510
Operating Profit
Operating ProfitCr
000000000000
OPM
OPM%
-20.8-400.01.12.14.04.5
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000000000000
Tax
TaxCr
000000000000
PAT
PATCr
000000000000
Growth YoY
PAT Growth YoY%
700.0-50.0100.0-400.0-12.5950.0266.7-128.6-9.5
NPM
NPM%
8.3700.01.01.23.33.4
EPS
EPS
0.00.00.00.00.00.00.10.30.00.00.00.0
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
00000021040611
Growth YoY
Revenue Growth YoY%
41.28,854.2-100.0-73.5
Expenses
ExpensesCr
00000021040510
Operating Profit
Operating ProfitCr
000000000000
OPM
OPM%
-20.8-400.01.12.14.04.5
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000000000000
Tax
TaxCr
000000000000
PAT
PATCr
000000000000
Growth YoY
PAT Growth YoY%
700.0-50.0100.0-400.0-12.5950.0266.7-128.6-9.5
NPM
NPM%
8.3700.01.01.23.33.4
EPS
EPS
0.00.00.00.00.00.00.10.30.00.00.00.0

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
000000000221020
Growth
Revenue Growth%
-6.5-100.042.28,954.9-53.8-4.9
Expenses
ExpensesCr
000000000211020
Operating Profit
Operating ProfitCr
000000000001
OPM
OPM%
-78.8-51.2-49.90.42.83.8
Other Income
Other IncomeCr
00000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000000000001
Tax
TaxCr
000000000000
PAT
PATCr
000000000001
Growth
PAT Growth%
-5.6-42.3-74.4102.6-77.5281.272.2-15.3189.0180.0-8.0132.0
NPM
NPM%
102.418.537.61.22.32.8
EPS
EPS
0.20.00.00.00.00.70.00.00.00.10.00.0
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
000000000221020
Growth
Revenue Growth%
-6.5-100.042.28,954.9-53.8-4.9
Expenses
ExpensesCr
000000000211020
Operating Profit
Operating ProfitCr
000000000001
OPM
OPM%
-78.8-51.2-49.90.42.83.8
Other Income
Other IncomeCr
00000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000000000001
Tax
TaxCr
000000000000
PAT
PATCr
000000000001
Growth
PAT Growth%
-5.6-42.3-74.4102.6-77.5281.272.2-15.3189.0180.0-8.0132.0
NPM
NPM%
102.418.537.61.22.32.8
EPS
EPS
0.20.00.00.00.00.70.00.00.00.10.00.0

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
444444444419
Reserves
ReservesCr
-1-1-1-1-1-1-1-1-1-12
Current Liabilities
Current LiabilitiesCr
000000000120
Non Current Liabilities
Non Current LiabilitiesCr
00000000000
Total Liabilities
Total LiabilitiesCr
3333333333221
Current Assets
Current AssetsCr
1110000003221
Non Current Assets
Non Current AssetsCr
22222333300
Total Assets
Total AssetsCr
3333333333221
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
444444444419
Reserves
ReservesCr
-1-1-1-1-1-1-1-1-1-12
Current Liabilities
Current LiabilitiesCr
000000000120
Non Current Liabilities
Non Current LiabilitiesCr
00000000000
Total Liabilities
Total LiabilitiesCr
3333333333221
Current Assets
Current AssetsCr
1110000003221
Non Current Assets
Non Current AssetsCr
22222333300
Total Assets
Total AssetsCr
3333333333221

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
000000000-244
Investing Cash Flow
Investing Cash FlowCr
00000000020
Financing Cash Flow
Financing Cash FlowCr
00000000021-4
Net Cash Flow
Net Cash FlowCr
00000000000
Free Cash Flow
Free Cash FlowCr
000000000-234
CFO To PAT
CFO To PAT%
-94.9-437.8-2,000.5579.0-2,790.3-435.4-253.4-389.6-66.5-9,426.01,566.3
CFO To EBITDA
CFO To EBITDA%
123.3228.6288.2-102.6132.690.4119.5140.850.1-25,697.81,286.6
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
000000000-244
Investing Cash Flow
Investing Cash FlowCr
00000000020
Financing Cash Flow
Financing Cash FlowCr
00000000021-4
Net Cash Flow
Net Cash FlowCr
00000000000
Free Cash Flow
Free Cash FlowCr
000000000-234
CFO To PAT
CFO To PAT%
-94.9-437.8-2,000.5579.0-2,790.3-435.4-253.4-389.6-66.5-9,426.01,566.3
CFO To EBITDA
CFO To EBITDA%
123.3228.6288.2-102.6132.690.4119.5140.850.1-25,697.81,286.6

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
11164613136244
Price To Earnings
Price To Earnings
8.916.035.0150.0133.064.855.9606.3326.3
Price To Sales
Price To Sales
9.925.924.80.613.711.9
Price To Book
Price To Book
0.30.30.42.11.72.20.76.712.1
EV To EBITDA
EV To EBITDA
-4.6-3.8-4.0-71.8-53.4-50.1180.2486.3329.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
83.911.41.42.2
OPM
OPM%
-78.8-51.2-49.90.42.83.8
NPM
NPM%
102.418.537.61.22.32.8
ROCE
ROCE%
3.33.32.50.10.81.11.91.53.94.71.41.4
ROE
ROE%
3.31.90.51.00.20.91.51.23.48.81.11.1
ROA
ROA%
3.11.80.51.00.20.81.41.13.30.81.11.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
11164613136244
Price To Earnings
Price To Earnings
8.916.035.0150.0133.064.855.9606.3326.3
Price To Sales
Price To Sales
9.925.924.80.613.711.9
Price To Book
Price To Book
0.30.30.42.11.72.20.76.712.1
EV To EBITDA
EV To EBITDA
-4.6-3.8-4.0-71.8-53.4-50.1180.2486.3329.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
83.911.41.42.2
OPM
OPM%
-78.8-51.2-49.90.42.83.8
NPM
NPM%
102.418.537.61.22.32.8
ROCE
ROCE%
3.33.32.50.10.81.11.91.53.94.71.41.4
ROE
ROE%
3.31.90.51.00.20.91.51.23.48.81.11.1
ROA
ROA%
3.11.80.51.00.20.81.41.13.30.81.11.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Integrated Proteins Ltd is a company in the middle of a deliberate reinvention. Founded in 1992 as a regional processor of oil seeds in Jamnagar, Gujarat, it had largely ceased operations by the early 2020s. A change in control in late 2024 and a rewritten corporate charter have since transformed it into a multi-segment enterprise, using its listed-company shell to enter a collection of unrelated new businesses - from textiles and securities trading to medical supplies and real estate - all within a single fiscal year. # Business segments Five businesses at vastly different stages - a legacy commodity trader, two newly launched operating segments, and two asset-holding shells with minimal or no revenue - assembled through a recent corporate reset. ## 1. Textiles: the largest new revenue stream **A trading business that appeared in the final quarter of the year and immediately became the company’s biggest sales contributor.** - **Bought and sold, not manufactured** - the segment trades in textiles, generating revenue of Rs. 461.62 lakhs in its first year, all of which came in the quarter ending March 2026. - **Asset-light trading model** - it held Rs. 184.70 lakhs in segment assets with no reported liabilities, suggesting the company finances inventory without taking on segment-level debt. - **Thin margin by design** - the segment earned a profit before tax and interest of just Rs. 5.24 lakhs on those sales, consistent with a high-volume, low-markup trading operation. ## 2. Agro & Trading: the legacy commodity business **The company’s original activity, now a minor contributor kept alive after the core processing operations were shut down.** - **What remains of a processor** - the company once manufactured and processed oil seeds like soyabean, mustard, and groundnut, but it has ceased all solvent extraction operations. - **A shrinking footprint** - segment assets stood at just Rs. 26.18 lakhs as of March 2026, reflecting a business that has been deliberately scaled back as the company pivots elsewhere. ## 3. Securities: the profit engine with the biggest balance sheet **A portfolio of investments that earns more than any other segment while holding the bulk of the company’s assets.** - **The real profit centre** - despite contributing only Rs. 94.34 lakhs in revenue, the segment delivered a profit before tax and interest of Rs. 23.98 lakhs, the highest of any unit. - **The company’s vault** - segment assets of Rs. 1,531.32 lakhs dominate the balance sheet, meaning most of the company’s capital is deployed in financial instruments rather than in its trading operations. ## 4. Medical: a placeholder with a licence **A business that exists on paper with assets deployed but virtually no commercial activity yet.** - **A single transaction** - the segment recorded revenue of Rs. 0.50 lakhs for the entire year, with an identical profit figure, indicating at most a token sale. - **Capital committed, not yet working** - segment assets of Rs. 150.00 lakhs have been allocated, so the company has put money behind the intent even though operations have not begun in earnest. ## 5. Real Estate: land and construction rights with no sales **A segment that holds assets and earns a small profit without generating any revenue.** - **No revenue, but a profit** - the segment reported nil sales for the year yet posted a profit before tax and interest of Rs. 4.85 lakhs, likely from ancillary income on its property holdings. - **Land bank and permissions** - the company’s amended charter now permits construction of roads, dams, and buildings, and dealing in land, while the board has approved the sale of surplus land to related parties and recommended it for member approval. - **Capital at rest** - segment assets of Rs. 150.54 lakhs are tied up in real estate that has yet to produce a sale. # Group structure and partners **A listed shell with no subsidiaries, a new controlling shareholder, and a promoter group that has fully exited.** - **No corporate group** - during the years under review, the company did not have any subsidiaries, joint ventures, or associate companies, and it contains no core investment company. - **Ownership changed hands in a week** - in December 2024, Siddheshwar Advisory Private Limited, a non-promoter entity, acquired a 19.72% stake from the sole promoter, Arvind K. Shah, via an off-market transfer; it bought a further 2.79% the next day to reach 23.53%. - **Promoters seeking reclassification** - by July 2026, ten individuals from the promoter group holding a combined 2.23% had asked to be reclassified as public shareholders, completing the separation from the original founders. - **Loans from the old guard** - the company has historically accepted unsecured loans from Mr. Arvind Shah, the former managing director, and has also lent money to outside parties, with Rs. 174 lakhs outstanding as of March 2024.

Documents — Integrated Proteins Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/y7z0199gn0hfrix0g0337s2j.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/uglryd45ss0ibqd0uizxg12s.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/rhd3lkkb7wcvhtpuhd5955ub.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/3mj6s3flmva330qpcun9hses.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/liw562pdnb0hpjnpxmbvbmsc.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/4i97u2ayjstsist36n3qmkqg.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/mm4xsmojk3mcfjmi58qi0j2j.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/6ebqqb89oizargj14u9nhxxh.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/0fftz01xb89dhacronw247i0.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/is6kcgrj6qurmucxhgtl85sr.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/lm58s9fqqrqmkf16z6chmobm.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/yj57byzcuouz1cr4xkqckh1o.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/ulvytx6rxmjdtjbzxpa5mhra.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/ljw0b31x0vpb736fua054hj0.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/9x7tcxmzmk61ghny4sago6vr.pdf